Masterclass Certificate in Nanomedicine Delivery Systems: Targeted Therapies
-- ViewingNowThe Masterclass Certificate in Nanomedicine Delivery Systems: Targeted Therapies is a comprehensive course that empowers learners with essential skills in the rapidly evolving field of nanomedicine. This certificate course highlights the importance of nanotechnology in developing advanced delivery systems for targeted therapies, addressing significant industry demands.
6,090+
Students enrolled
GBP £ 149
GBP £ 215
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Fundamentals of Nanomedicine Delivery Systems: An introduction to the field of nanomedicine, including the basic principles and applications of nanoparticle-based drug delivery systems. This unit will cover the history, current state and future prospects of nanomedicine, as well as the fundamentals of nanoparticle synthesis and characterization. ⢠Design and Fabrication of Nanoparticle-Based Drug Carriers: This unit will focus on the design, synthesis, and characterization of various types of nanoparticle-based drug carriers, including liposomes, polymeric nanoparticles, inorganic nanoparticles, and dendrimers. Emphasis will be placed on the mechanisms of nanoparticle synthesis, the factors that influence nanoparticle properties, and the techniques used to characterize nanoparticle size, shape, surface charge, and stability. ⢠Targeted Drug Delivery: Principles and Strategies: This unit will explore the principles and strategies of targeted drug delivery using nanoparticle-based drug carriers. Topics will include the use of active and passive targeting mechanisms, the design of ligand-targeted nanoparticles, and the use of stimuli-responsive nanoparticles. The unit will also cover the challenges and limitations of targeted drug delivery and the potential strategies for overcoming these obstacles. ⢠Nanomedicine in Cancer Therapy: This unit will focus on the use of nanomedicine in cancer therapy, including the development of nanoparticle-based drug carriers for the targeted delivery of chemotherapeutic agents, small molecule inhibitors, and siRNA. The unit will cover the unique challenges of cancer therapy, including the heterogeneity of tumors, the development of drug resistance, and the need for combination therapy. ⢠Nanomedicine in Immunotherapy: This unit will explore the use of nanomedicine in immunotherapy, including the development of nanoparticle-based drug carriers for the targeted delivery of immunomodulatory agents, vaccines, and cell-based therapies. The unit will cover the unique challenges of immunotherapy, including the complexity
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
